Fig. 1. C'aldesmon irihihitiori of steady-state force
Four rabbit psoas fibres were mounted on a tension-measuring apparatus and lowered into a 300 pl thermostatically controlled chamber. This preparation was treated with the KCI/Tris buffer as described in the text. Solutions were continuously perfused at a rate of 1 ml/min at 25°C. Initial bathing medium was 5 rnu-Pipes (pH 7.11, 5 mM-EGTA, 50 mM-KCI, 5 mM-MgCI,, 1.5 mM-NaN,. Contraction was initiated by addition of 4 mM-MgATP to this solution which also included 4 pM-caldesmon at the times indicated. Maximum tension was obtained when 4 mM-CaClz together with MgATP was added to the 'EGTA' solution.
mM-NaN,) at resting length having been washed in the K C l / Tris buffer. Adding 4 pM-caldesmon to the fibres in MgATP gives a contraction 82% of that obtained in the absence of caldesmon. After adding Ca2+ in MgATP, the tension is seen to increase more. This is reduced by returning to EGTA. Readdition of caldesmon then causes another tension dropthe percentage inhibition of force at 4 pM-caldesmon from nine experiments being 24% k 5.6 (mean k S.D.). This effect of caldesmon was dose dependent following brief incubations ( ,< 5 min) at various concentrations. Maximal inhibition of force of up to 48% with 15 pM-caldesmon was obtained with the half-maximal inhibition typically in the range 2-4 P M .
Additional information about the effect of caldesmon on cross-bridge interactions can be obtained by imposing a shortening (0.2-0.3%) of the muscle length and monitoring the ensuing tension changes in conditions with or without caldesmon. Data from four preparations indicate that caldesmon, at concentrations of 4 and 6 p~, does not alter the specific muscle stiffness [(dt/dl)/ T, the instantaneous change in tension with length] nor the rate of recovery of force following the length change.
Hence we conclude that caldesmon has the ability to control steady-state isometric force of contraction and seems to do so by reducing the number of interacting cross-bridges rather than altering the individual properties of the crossbridges. The thin filament regulatory system of smooth muscle can therefore control contractility.
The work presented here was supported by the M.R.C. contractions at 25"c in MgATP Occur without any Ca2+ [62.7%+9.2%of that inCa2+ ( m e a n k s .~. , n=9)].The 'desensitized' preparation is suitable for the investigation of the effects of caldesmon.
A typical experiment is illustrated in Fig. 1 . The preparation is bathing in 'rigor' solution (composition: 5 mM-Pipes (pH 7.1, 25"C), 5 mM-EGTA, 50 mM-KCI, 5 mM-MgCl,, 1.5 Leukotrienes are a group of molecules which are synthesized from arachidonic acid by the action of a 5-lipoxygenase. They are produced by many different types of cells in response to various stimuli and they cause a variety of effects (reviewed by Hammarstrom, 1983) . lnfusion of leukotrienes LTC, and LTD, into isolated perfused guinea-pig or rat hearts causes vasoconstriction (Letts & Piper, 1982; Roth & Lefer, 1983; Bittl et al., 1985) . This effect is blocked by leukotriene receptor antagonists and also by indomethacin, a cyclo-oxygenase inhibitor; it has been suggested that indomethacin is effective because leukotrienes act partly by stimulating thromboxane synthesis.
In an earlier publication (Garlick & Steinhardt, 1984) we reported that when the coronary effluent from a bufferperfused heart was used as the perfusion medium for the same or a different heart, a profound vasoconstriction was observed. We found that this effect was blocked by indomethacin and also by the more specific cyclo-oxygenase inhibitor, flurbiprofen. We now report the results of further experiments we have carried out which suggest that this effect is mediated by leukotrienes.
Male Wistar rats (250-300 g) were lightly anaesthetized and heparinized, and their hearts were then excised and perfused in a non-recirculating Langendorff system at constant pressure (125 cmH,O) with a modified Krebs buffer containing 11 mM-glucose and gassed with 95% 0, + 5% CO, (v/v) .
After collecting the coronary effluent for 2 h, glucose was readded and the effluent was then re-filtered (0.22 p m filter) and stored for up to 48 h at 4°C. In a separate series of experiments, a perfusion system with two matched reservoirs (A and B) was used. Hearts were perfused for a 2 h stabilization period with buffer from reservoir A, during which time the coronary flow was recorded every 10 min for the first 110 min and then every minute for the following 10 min. At 120 min, the perfusing medium was changed from buffer to coronary effluent by first releasing the clamp on the inlet from reservoir B and then clamping the inlet from reservoir A; the coronary flow was then recorded every minute for 30 min.
The results obtained are illustrated in Fig. 1 . When the perfusion medium is changed from buffer to coronary effluent, a transient increase is observed (possibly due to pressure changes caused by unclamping the inlet from reservoir B) followed by a sustained vasoconstriction, such that by 1 0 min. the flow is only 78 k 2% ( II = 8. s.E.M.) of its original value. When the leukotriene receptor blocker, FPL 557 12 (3.8 p~) is added to the effluent, a larger transient increase is observed, but at 10 min the flow is still 104 + 3% ( a = 6) of its original value. Leukotriene-depleted effluent was collected in the presence of the leukotriene synthesis inhibitor AA861 ( l p~) .
When this effluent is used as the perfusing medium, the coronary flow at 10 min is 98 + 2% ( IZ = 6 ) of its original value.
T h e effluent was analysed for leukotrienes LTC,, LTD, and LTE, by radioimmunoassay after separation by h.p.1.c. (Beaubien et al., 1984) . T h e analysis showed that the total amounts released over 2 h were 9, 5 and 32 pmol of LTC,, LTD, and LTE,, respectively. A leukotriene 'cocktail' was therefore made from these three synthetic leukotrienes such that when it was infused into a buffer-perfused heart at 1/20 of the coronary flow rate, the concentrations reaching the heart would be the same as the average concentration measured in the effluent; as can be seen from Fig. I , the infusion resulted in a vasoconstriction which is almost identical to that obtained with the 'control' effluent.
In conclusion, we have shown that isolated, unstimulated, buffer-perfused rat hearts synthesize leukotrienes LTC4, LTD, and LTE, in significant amounts. We would suggest that the vasoconstriction caused by these compounds may play a role in the deterioration of isolated. recirculating heart preparations such as the working heart.
